TG Therapeutics Inc (TGTX)
13.67
-0.32
(-2.29%)
USD |
NASDAQ |
Apr 19, 15:48
TG Therapeutics Accounts Payable (Quarterly)
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | 34.66M |
| June 30, 2020 | 29.67M |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 40.20M |
| December 31, 2018 | |
| September 30, 2018 | 37.92M |
| June 30, 2018 | 35.39M |
| March 31, 2018 | 32.51M |
| December 31, 2017 | |
| September 30, 2017 | 18.18M |
| June 30, 2017 | |
| March 31, 2017 | 18.92M |
| December 31, 2016 | 15.27M |
| September 30, 2016 | 15.55M |
| June 30, 2016 | 13.08M |
| March 31, 2016 | 8.139M |
| December 31, 2015 | 9.346M |
| September 30, 2015 | 8.583M |
| June 30, 2015 | 8.254M |
| March 31, 2015 | 8.880M |
| December 31, 2014 | 3.992M |
| September 30, 2014 | 7.968M |
| Date | Value |
|---|---|
| June 30, 2014 | 1.899M |
| March 31, 2014 | 1.639M |
| December 31, 2013 | 4.764M |
| September 30, 2013 | 4.325M |
| June 30, 2013 | 2.248M |
| March 31, 2013 | 1.388M |
| December 31, 2012 | 1.117M |
| September 30, 2012 | 1.799M |
| June 30, 2012 | 0.3217M |
| March 31, 2012 | 0.4675M |
| December 31, 2011 | 0.6666M |
| September 30, 2011 | 0.1677M |
| June 30, 2011 | 0.2076M |
| March 31, 2011 | 0.1833M |
| December 31, 2010 | 0.2235M |
| September 30, 2010 | 0.3958M |
| June 30, 2010 | 0.3738M |
| March 31, 2010 | 0.3027M |
| December 31, 2009 | 0.2912M |
| September 30, 2009 | 0.1431M |
| June 30, 2009 | 0.1729M |
| March 31, 2009 | 0.1445M |
| December 31, 2008 | 0.5423M |
| September 30, 2008 | 0.7053M |
| June 30, 2008 | 0.6173M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
29.67M
Minimum
Jun 2020
34.66M
Maximum
Sep 2020
32.16M
Average
32.16M
Median
Accounts Payable (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 15.12M |
| Geron Corp | 6.161M |
| Editas Medicine Inc | 8.269M |
| G1 Therapeutics Inc | 3.992M |
| Mersana Therapeutics Inc | 7.319M |